The Brian Allman Diffuse Large B Cell Lymphoma (DLBCL) Novel Therapeutics Program

Photos

Brian during treatment

Brian during treatment

Brian during treatment

Brian during treatment

Brian settled in

Brian during treatment

Brian during treatment

Brian & his lifesaver Betsy

Brian during treatment

Brian during treatment

Brian during treatment

Brian's daily bounty


The Brian Allman Diffuse Large B Cell Lymphoma (DLBCL) Novel Therapeutics Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.

Federal Tax I.D.: EIN 86-0818253